Common Anti-Inflammatory drug could help millions avoid heart valve surgery
NCT ID NCT05162742
Summary
This study is testing whether colchicine, an anti-inflammatory medication, can slow the progression of aortic valve stenosis—a serious heart condition where the main heart valve narrows. Researchers are enrolling 150 patients with moderate but symptom-free valve narrowing to see if daily colchicine reduces calcium buildup and delays the need for valve replacement surgery. If successful, this could become the first medication treatment for this common heart disease that currently requires risky surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Radboudumc
Nijmegen, The Netherlands, Netherlands
Conditions
Explore the condition pages connected to this study.